Longer times from symptom onset to randomization equaled a smaller—or perhaps no—advantage for Impella vs standard care.

Therapy initiated within national treatment-time goals set a decade ago for patients with ST-segment elevated myocardial infarction (STEMI) remains associated with improved survival in recent years.

Despite underrepresentation in clinical trials of acute coronary syndrome treatments, a recent study suggests treatment strategies and outcomes in chronic kidney disease patients with ST-elevation ...

Please provide your email address to receive an email when new articles are posted on . WASHINGTON — New, 2-year data from a global registry enrolling patients with STEMI in low- and middle-income ...

Every year, three million people have what’s known as STEMI, or ST Elevated Myocardial Infarction, where one of the main arteries to the heart is 100-percent blocked. “The heart muscle is dying, and ...

Door-to-balloon times were no higher than when cath lab staff donned traditional lead aprons in this single-center experience ...

In a recent study published in the European Heart Journal - Quality of Care and Clinical Outcomes, researchers predicted long-term health consequences and expenses associated with ST-elevation ...

The elderly account for the majority of medical spending in many countries, raising concerns about potentially unnecessary spending, especially during the final months of life. Using a well-defined ...

ATLANTA -- Routine use of the Impella CP microaxial flow pump significantly improved survival in patients with infarct-related cardiogenic shock, the randomized DanGer Shock trial showed. In more than ...

Circulating ketone bodies (KBs) are substantially elevated at presentation and 24 hours after ST-segment elevation myocardial infarction (STEMI), according to new research. The study also showed that ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. ATLANTA — In the setting of concomitant STEMI and ...